HRD MM constitutes the largest genetic sub-group of patients, with substantial heterogeneity.17 We describe two sub-groups of HRD with either gain(11q25) and CCND1 biology or gain(1q21) and CCND2 overexpression. Here, CCND2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.